Systematic Review on Customized and Non-customized Device Techniques for the Endovascular Repair of the Aortic Arch

医学 主动脉弓 主动脉修补术 死亡率 外科 动脉瘤 主动脉
作者
Petroula Nana,Κωνσταντίνος Σπανός,Konstantinos Dakis,Athanasios D. Giannoukas,Tilo Kölbel,Stéphan Haulon
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:31 (4): 505-521 被引量:17
标识
DOI:10.1177/15266028221133701
摘要

Purpose: Open repair remains the standard of care for aortic arch pathologies. However, endovascular management became an attractive alternative for high-risk patients. This study aimed to assess the outcomes of the available endovascular techniques for aortic arch pathology management. Materials and Methods: A search of the English literature (2000–2022) using PubMed, EMBASE, via Ovid, and CENTRAL databases (February 1, 2022) was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Studies reporting on patients with aortic arch pathologies managed with custom-made devices ([CMDs] fenestrated or branched thoracic endovascular aortic repair [F/BTEVAR]) and non-CMDs (parallel graft or surgeon-modified FTEVAR) were eligible. Studies reporting on hybrid or open repair were excluded. Studies’ quality was assessed using the Newcastle-Ottawa Scale. Primary outcomes were technical success, 30 day mortality, and cerebrovascular events (CVEs). Secondary outcomes were re-intervention and mortality during follow-up. Results: Thirty studies (2135 patients) were included. Treatment indications were mainly dissections (652 cases [48.0%, 652/1358]; 90 type A, 506 type B; 364 acute, 163 chronic) and aneurysms (46.9%, 582/1239). Five studies (211 patients) reported on FTEVAR and 10 (388 patients) on BTEVAR. For FTEVAR, technical success rate was 98.3%. Thirty-day mortality was 3.8% and CVE rate was 12.3%. Ten deaths (9.7%) and 19 re-interventions (9%) were recorded during follow-up (24 months). Regarding BTEVAR, technical success rate was 98.7%, and 30 day mortality and CVE rates were 5.4% and 11.0%, respectively. During follow-up (27 months), 64 deaths (18.7%) and 33 re-interventions (9.6%) were recorded. Parallel graft technique was reported in 11 studies (901 patients). Technical success rate was 76.4%. Thirty-day mortality was 3.9% and 32 (4.3%) CVEs were recorded. Thirty-five deaths (4.4%) and 43 re-interventions (5.5%) were reported during follow-up (27 months). Surgeon-modified FTEVAR was described in 5 studies (635 patients). Technical success rate was 91.6%. At 30 days, 15 deaths (2.3%) and 22 CVEs (3.5%) were recorded. During follow-up (19 months), 26 deaths (4.2%) and 21 re-interventions (3.6%) were detected. Conclusions: Endovascular arch repair presented a variable technical success; >95% for F/BTEVAR; ≤90% for non-CMDs. Acceptable 30 day mortality rates were reported. Cerebrovascular event rates ranged up to 10%. These findings, adjacent to the estimated midterm mortality and re-interventions, set the need for further improvement. Clinical Impact Endovascular arch repair gains popularity as a valuable alternative, especially in patients considered unfit for open repair. According the available literature, any endovascular technique, including custom-made or off-the-shelf solutions, may be applied successfully, with acceptable early mortality. However, the perio-operative cerebrovascular event rate is still an issue, indicating the need for further advancements.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
cesar完成签到,获得积分10
刚刚
细腻海蓝发布了新的文献求助10
1秒前
紧张的刺猬完成签到,获得积分10
1秒前
萌酱完成签到,获得积分10
1秒前
LZ发布了新的文献求助10
1秒前
梵高完成签到,获得积分10
1秒前
余慕康发布了新的文献求助50
2秒前
吹雪完成签到,获得积分0
2秒前
最短的咒完成签到,获得积分10
2秒前
WHT完成签到,获得积分10
2秒前
隐形曼青应助科研通管家采纳,获得10
2秒前
风中虔纹完成签到,获得积分10
2秒前
2秒前
慕青应助甲乙丙丁采纳,获得10
2秒前
桐桐应助科研通管家采纳,获得10
2秒前
过奖啦完成签到,获得积分10
2秒前
2秒前
在水一方应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
狐尔莫发布了新的文献求助10
3秒前
Foch发布了新的文献求助10
3秒前
zy完成签到,获得积分10
3秒前
4秒前
研友_ZAxQqn完成签到,获得积分10
4秒前
4秒前
shifeng发布了新的文献求助10
4秒前
聪慧的松鼠完成签到,获得积分10
4秒前
善学以致用应助踏月偷心采纳,获得10
4秒前
舒心的耷完成签到,获得积分10
5秒前
酷炫小馒头完成签到,获得积分10
5秒前
付银薇完成签到,获得积分10
6秒前
acadedog完成签到,获得积分10
6秒前
zhizhiman发布了新的文献求助10
6秒前
llly完成签到,获得积分10
7秒前
飘逸锦程完成签到 ,获得积分10
7秒前
lxj完成签到,获得积分10
7秒前
cui123完成签到 ,获得积分10
8秒前
9秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968637
求助须知:如何正确求助?哪些是违规求助? 3513552
关于积分的说明 11168493
捐赠科研通 3248935
什么是DOI,文献DOI怎么找? 1794554
邀请新用户注册赠送积分活动 875188
科研通“疑难数据库(出版商)”最低求助积分说明 804691